UBS ASSET MANAGEMENT AMERICAS LLC - REGENXBIO INC ownership

REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 179 filers reported holding REGENXBIO INC in Q2 2018. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of REGENXBIO INC
ValueSharesWeighting
Q3 2023$634,435
+32.6%
38,544
+52.3%
0.00%
Q2 2023$478,5560.0%25,3070.0%0.00%
Q1 2023$478,556
-38.8%
25,307
-26.6%
0.00%
Q4 2022$782,415
-99.9%
34,498
-5.5%
0.00%
-100.0%
Q3 2022$964,563,000
+7.0%
36,4950.0%0.00%
Q2 2022$901,426,000
-28.1%
36,495
-3.4%
0.00%
-100.0%
Q1 2022$1,254,249,000
+1.5%
37,7900.0%0.00%
Q4 2021$1,235,732,000
-22.0%
37,7900.0%0.00%
-100.0%
Q3 2021$1,584,157,000
+3.4%
37,790
-4.2%
0.00%0.0%
Q2 2021$1,532,360,000
+22.0%
39,443
+7.1%
0.00%0.0%
Q1 2021$1,256,305,000
+3.0%
36,831
+37.0%
0.00%0.0%
Q4 2020$1,219,730,000
+64.8%
26,8900.0%0.00%
Q3 2020$740,013,000
-25.3%
26,8900.0%0.00%
-100.0%
Q2 2020$990,359,000
+36.8%
26,890
+20.2%
0.00%0.0%
Q1 2020$724,178,000
-85.4%
22,365
-81.5%
0.00%
-66.7%
Q4 2019$4,962,450,000
+15.8%
121,124
+0.6%
0.00%0.0%
Q3 2019$4,286,418,000
-30.3%
120,405
+0.6%
0.00%
-25.0%
Q2 2019$6,149,708,000
-9.8%
119,714
+0.6%
0.00%
-20.0%
Q1 2019$6,817,713,000
+48.7%
118,962
+8.8%
0.01%
+25.0%
Q4 2018$4,586,143,000
-47.5%
109,324
-5.6%
0.00%
-33.3%
Q3 2018$8,739,201,000
+904.7%
115,751
+854.8%
0.01%
+500.0%
Q2 2018$869,825,000
+47983.2%
12,123
-88.9%
0.00%
-50.0%
Q4 2015$1,809,000
-30.9%
108,954
-8.3%
0.00%
-33.3%
Q3 2015$2,619,000118,8630.00%
Other shareholders
REGENXBIO INC shareholders Q2 2018
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 1,459,128$110,164,0006.60%
ArchPoint Investors 224,187$16,926,0004.60%
Redmile Group, LLC 1,656,065$125,033,0003.85%
WS MANAGEMENT LLLP 954,812$72,088,0002.37%
HIGHLINE CAPITAL MANAGEMENT, L.P. 342,000$25,821,0001.19%
Perceptive Advisors 470,672$35,536,0000.95%
Pier Capital, LLC 94,492$7,134,0000.90%
Ipswich Investment Management Co., Inc. 29,932$2,260,0000.76%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 275,000$20,763,0000.74%
Timpani Capital Management LLC 27,835$2,102,0000.61%
View complete list of REGENXBIO INC shareholders